Consistent with the in vitro results, EFNB2 re-expression abrogated the suppressive effects of ITGA5 depletion on xenograft growth, tumor cell proliferation (as assessed by Ki-67 index), and tumor angiogenesis (as assessed by CD31 index) (Figure 6E-H). This evidence concerns the gene ITGA5 and neoplasm.